In Practice: Changes to dual-labelled medicine ingredient names The TGA has advised that more dual-labelled medicine ingredient names have begun the transition to sole ingredient names.
‘Stopping antidepressants or not?’ New research says collaborative primary care planning between GPs and patients is key to decisions around prescribing and cessation.
TGA approves HRT patch alternatives The ongoing short supply of hormone replacement therapy patches has resulted in the approval of a range of overseas alternatives.
New step-by-step care transition guide for GPs A first-of-its-kind, practical resource is now available to GPs, designed to help navigate the often high-risk task of moving patients between care providers.
Coroner stresses need for complete discharge summaries A quality care expert says findings around a woman’s death from prescription medications are a reminder of the importance of continuity of care.
Most GPs discover medication shortages through patients: Poll A new survey highlights the urgency of improving measures to communicate supply chain disruptions, with patients increasingly feeling an impact.
TGA updates montelukast safety information Extra information is being added to all products to highlight the existing warnings, as a ‘reminder to watch out’ for side effects.
Prescriptions for most popular statins on the rise Data shows the number of people using the most popular statins is increasing, while the cost for COVID-19 antivirals has fallen.
Quetiapine shortage ‘frankly unacceptable’ Some doses of the antipsychotic medication could be in shortage until July, leaving both patients and GPs ‘alarmed’.
In Practice: Register now for the Clinical Update The RACGP conference will be held on the Gold Coast in February, with this year’s theme focussing on the future of healthcare.